Induction of analgesia by central administration of ORG 2766, an analog of ACTH4--9.
Dose-dependent analgesia was produced by microinjection of ORG 2766 into the periaqueductal gray (PAG). This analgesia was found to be potent and long-lasting and occurred at doses which were equimolar to those necessary for morphine analgesia. The same doses failed to produce analgesia by the cerebroventricular route, suggesting that the PAG was the site of action of this effect. Naloxone failed to reduce the analgesia and morphine tolerant did not diminish the effect significantly. Additionally, ORG 2766 at concentrations up to 10 micrometer failed to inhibit binding of [3H]naloxone to brain opiate receptors in vitro. These results suggest a non-opiate mechanism of action and are discussed in terms of a proposed alpha-MSH or ACTH receptor.
D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D000700:Analgesics / Q000008:administration & dosage; D000818:Animals; D001921:Brain; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D007267:Injections; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D010446:Peptide Fragments / Q000008:administration & dosage / Q000494:pharmacology*; D011957:Receptors, Opioid / Q000378:metabolism
D000700:Analgesics; D010446:Peptide Fragments; D011957:Receptors, Opioid; D009270:Naloxone; C013765:Org 2766; D009020:Morphine; D000324:Adrenocorticotropic Hormone